HERE TO MAKE THERAPY PERSONAL.

We’ll meet you wherever you are in your experience. Select your path below.


It’s important to know how to inject, when to inject, and where to inject. Call Teva’s Shared Solutions® now at 1-800-887-8100 to schedule your free, in-home, 1-on-1 injection training.

Not yet comfortable with manual injections?

The autoject®2 for glass syringe can be a helpful tool. This automatic injection device hides the needle, allowing you to administer COPAXONE® at the touch of a button. And it’s available free of charge to anyone taking Teva’s COPAXONE® with a doctor’s prescription. Order yours through Teva’s Shared Solutions®.

An image of the autoject®2 for glass syringe used for administration and usage of COPAXONE®. An image of the autoject®2 for glass syringe used for administration and usage of COPAXONE®.

Both 3-times-a-week COPAXONE® 40 mg and daily COPAXONE® 20 mg are given just under the skin (subcutaneously). They can be administered with the autoject®2 for glass syringe or administered manually.1

Ready for fewer injections?

Ask your doctor about 3-times-a-week COPAXONE® 40 mg. It can be administered with the autoject®2 for glass syringe or administered manually.1

Autoject Autoject

With 3-times-a-week COPAXONE® 40 mg, you’re in control of your MS therapy ROUTINE.

  • Choose a consistent (approximately the same time and on the same days each week) 3-times-a-week schedule that works for you (example: Monday, Wednesday, and Friday); injections must be at least 48 hours apart.1

  • 3-times-a-week COPAXONE® 40 mg and daily COPAXONE® 20 mg are not interchangeable. COPAXONE® 40 mg is started 1-2 days after your last dose of COPAXONE® 20 mg.

Wherever you are in your therapy experience, training matters.

Even if you have used an injectable therapy before, you should be trained by a doctor or nurse before injecting COPAXONE® for the first time. Call Teva’s Shared Solutions® at 1-800-887-8100 to schedule a free, in-home, 1-on-1 injection training when you start COPAXONE® therapy.

Use

COPAXONE® is a prescription medicine that is used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Important Safety Information

Do not use COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Serious side effects may happen right after or within minutes after you inject COPAXONE® at any time during your course of treatment. Call your doctor right away if you have any of these immediate post-injection reaction symptoms including: redness to your cheeks or other parts of the body (flushing); chest pain; fast heart beat; anxiety; breathing problems or tightness in your throat; or swelling, rash, hives, or itching. If you have symptoms of an immediate post-injection reaction, do not give yourself more injections until a doctor tells you to.

You can have chest pain as part of an immediate post-injection reaction or by itself. This type of chest pain usually lasts a few minutes and can begin around 1 month after you start using COPAXONE®. Call your doctor right away if you have chest pain while using COPAXONE®.

Damage to the fatty tissue just under your skin’s surface (lipoatrophy) and, rarely, death of your skin tissue (necrosis) can happen when you use COPAXONE®. Damage to the fatty tissue under your skin can cause a “dent” at the injection site that may not go away. You can reduce your chance of developing these problems by following your doctor’s instructions for how to use COPAXONE® and choosing a different injection area each time you use COPAXONE®.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the injection site; rash; shortness of breath; flushing; and chest pain.

Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of COPAXONE®. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information in the full Prescribing Information.

Reference: 1. COPAXONE® (glatiramer acetate injection) Current Prescribing Information. Teva Neuroscience, Inc.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave COPAXONE.com and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?